Eton Pharmaceuticals, Inc.ETONNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 25.45% |
| Q2 2025 | -64.44% |
| Q1 2025 | -162.88% |
| Q4 2024 | -195.37% |
| Q3 2024 | 120.62% |
| Q2 2024 | -274.97% |
| Q1 2024 | 64.05% |
| Q4 2023 | -289.64% |
| Q3 2023 | -112.70% |
| Q2 2023 | 271.39% |
| Q1 2023 | -391.67% |
| Q4 2022 | 129.95% |
| Q3 2022 | -95.44% |
| Q2 2022 | 70.77% |
| Q1 2022 | -612.99% |
| Q4 2021 | 117.05% |
| Q3 2021 | -202.28% |
| Q2 2021 | -139.41% |
| Q1 2021 | 166.55% |
| Q4 2020 | -18.19% |
| Q3 2020 | -37.51% |
| Q2 2020 | 47.73% |
| Q1 2020 | -235.65% |
| Q4 2019 | 45.70% |
| Q3 2019 | -52.82% |
| Q2 2019 | 56.15% |
| Q1 2019 | -98.66% |
| Q4 2018 | -28.18% |
| Q3 2018 | 5.58% |
| Q2 2018 | -2.12% |
| Q1 2018 | 58.03% |
| Q4 2017 | -156.62% |
| Q3 2017 | -23.16% |
| Q2 2017 | 0.00% |